iRhythm Holdings (IRTC) Cash from Operations Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | -231.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -231.68% |
| Dec 31, 2025 | 36.29% |
| Sep 30, 2025 | 43.27% |
| Jun 30, 2025 | 133.61% |
| Mar 31, 2025 | 84.83% |
| Dec 31, 2024 | 220.41% |
| Sep 30, 2024 | 1,935.70% |
| Jun 30, 2024 | 358.97% |
| Mar 31, 2024 | -69.18% |
| Dec 31, 2023 | -227.00% |
| Sep 30, 2023 | -67.40% |
| Jun 30, 2023 | -1,129.03% |
| Mar 31, 2023 | 20.91% |
| Dec 31, 2022 | 196.40% |
| Sep 30, 2022 | -79.24% |
| Jun 30, 2022 | 31.49% |
| Mar 31, 2022 | 7.07% |
| Dec 31, 2021 | -266.86% |
| Sep 30, 2021 | 61.55% |
| Jun 30, 2021 | 94.65% |
| Mar 31, 2021 | -87.08% |
| Dec 31, 2020 | 260.86% |
| Sep 30, 2020 | 1,370.85% |
| Jun 30, 2020 | -1,094.42% |
| Mar 31, 2020 | -30.32% |
| Dec 31, 2019 | -11.14% |
| Sep 30, 2019 | 83.11% |
| Jun 30, 2019 | 116.05% |
| Mar 31, 2019 | -29.43% |
| Dec 31, 2018 | -17.46% |
| Sep 30, 2018 | -34.56% |
| Jun 30, 2018 | -535.66% |
| Mar 31, 2018 | -107.22% |
| Dec 31, 2017 | -296.91% |
| Sep 30, 2017 | -61.26% |
| Jun 30, 2017 | 74.17% |
| Mar 31, 2017 | 32.56% |
| Dec 31, 2016 | 83.23% |